Status:
COMPLETED
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
The purpose is to investigate safety and tolerability of single and multiple ascending inhaled doses of AZD4818 in healthy Japanese male volunteers.
Eligibility Criteria
Inclusion
- Provision of informed consent
- Body Mass Index (BMI) between 18.0-27.0 kg/m2
- No clinically relevant abnormal findings
Exclusion
- Acute illness which requires medical intervention
- Definite or suspected personal history of adverse drug reactions or drug hypersensitivity.
- Clinical relevant disease or disorder (past or present)
- A history of respiratory disorders
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00687232
Start Date
January 1 2008
End Date
May 1 2008
Last Update
December 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Osaka, Osaka, Japan